世界のがん画像処理ソフトウェア市場は、2025年に4368百万米ドルと算定されており、2026年には4565百万米ドルとなる見通しです。2026年から2032年の期間においては年平均成長率（CAGR）5.0%で推移し、2032年には6117百万米ドルに達すると予測されています。

がん画像処理ソフトウェアの市場規模、推定値、予測値は売上収益で提示され、2025年を基準年とし、2021年から2032年までの過去データと予測データを含みます。本レポートは定量的・定性的分析を組み合わせ、企業が成長戦略の策定、競争環境の評価、現在の市場における自社の位置付けの分析、がん画像処理ソフトウェアに関する情報に基づいたビジネス判断を行うことを支援します。
報告対象範囲
売上高予測、企業シェア、競争環境、成長要因および市場トレンド

市場セグメンテーション
企業一覧
Mirada
GE HealthCare
Mint Medical
Imaris
Varian
DOSIsoft
Certis Oncology
MIM Software Inc.
Arterys
SIEMENS
Brainomix
Oncology Systems Limited


タイプ別
CT
MRI
MRA
Others


用途別
Clinical Routine
Clinical Trials


地域別
北米（アメリカ、カナダ、メキシコ）
欧州（ドイツ、フランス、イギリス、イタリアなど）
アジア太平洋（中国、日本、韓国、東南アジア、インドなど）
南米（ブラジルなど）
中東・アフリカ（トルコ、GCC諸国、アフリカなど）
グローバルがん画像処理ソフトウェア市場を包括的にセグメント化しております。地域別市場規模、タイプ別、用途別、およびプレイヤー別の市場規模も提供されます。より深い洞察を得るため、本レポートでは競争環境、主要競合他社、それぞれの市場順位を分析し、技術動向や新製品開発について論じております。
本レポートの構成
第1章：がん画像処理ソフトウェア市場の調査範囲および各市場セグメント（タイプ別、用途別など）のエグゼクティブサマリーを紹介いたします。市場規模や将来の発展可能性を含め、現状ならびに短期・中期・長期の動向について概観を提供いたします
第2章：がん画像処理ソフトウェアの世界市場規模および地域別市場規模の概要を提示いたします。あわせて、市場トレンド、最新動向、成長を促進する要因と抑制要因、業界企業が直面する課題・リスク、関連政策について分析いたします
第3章：がん画像処理ソフトウェア市場における企業の競争環境、収益シェア、最新の事業計画、合併・買収（M&A）情報などを詳細に分析いたします
第4章：がん画像処理ソフトウェア市場をタイプ別に分類し、各セグメントの市場規模および成長余地を提示いたします
第5章：がん画像処理ソフトウェア市場を用途別に整理し、各セグメントの市場規模および拡大可能性を明らかにいたします
第6章～第10章：がん画像処理ソフトウェア市場について、北米、欧州、アジア太平洋、中南米、中東・アフリカを対象に国別分析を実施いたします。各地域および主要国の市場規模、発展可能性、生産能力、市場の成熟度、将来見通しを定量的に評価いたします
第11章：がん画像処理ソフトウェア市場の主要プレイヤーの企業プロファイルを提供いたします。収益、粗利益率、製品ポートフォリオ、最近の事業展開などを網羅的に整理いたします
第12章：がん画像処理ソフトウェア市場に関する重要な知見を総括し、結論を提示いたします
第13章：付録（調査方法論）

The global Cancer Imaging Software market was valued at US$ 4368 million in 2025 and is anticipated to reach US$ 6117 million by 2032, at a CAGR of 5.0% from 2026 to 2032.

Cancer Imaging Software has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

The North American market for Cancer Imaging Software is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Cancer Imaging Software is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Cancer Imaging Software in Clinical Routine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Cancer Imaging Software include Mirada, GE HealthCare, Mint Medical, Imaris, Varian, DOSIsoft, Certis Oncology, MIM Software Inc., Arterys, SIEMENS, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Cancer Imaging Software market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cancer Imaging Software. The Cancer Imaging Software market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Cancer Imaging Software market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Cancer Imaging Software manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation
By Company
Mirada
GE HealthCare
Mint Medical
Imaris
Varian
DOSIsoft
Certis Oncology
MIM Software Inc.
Arterys
SIEMENS
Brainomix
Oncology Systems Limited

Segment by Type
CT
MRI
MRA
Others

Segment by Application
Clinical Routine
Clinical Trials

By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA

Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Cancer Imaging Software companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Imaging Software Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 CT
1.2.3 MRI
1.2.4 MRA
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cancer Imaging Software Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Clinical Routine
1.3.3 Clinical Trials
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Cancer Imaging Software Market Perspective (2021–2032)
2.2 Global Cancer Imaging Software Growth Trends by Region
2.2.1 Global Cancer Imaging Software Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Cancer Imaging Software Historic Market Size by Region (2021–2026)
2.2.3 Cancer Imaging Software Forecasted Market Size by Region (2027–2032)
2.3 Cancer Imaging Software Market Dynamics
2.3.1 Cancer Imaging Software Industry Trends
2.3.2 Cancer Imaging Software Market Drivers
2.3.3 Cancer Imaging Software Market Challenges
2.3.4 Cancer Imaging Software Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cancer Imaging Software Players by Revenue
3.1.1 Global Top Cancer Imaging Software Players by Revenue (2021–2026)
3.1.2 Global Cancer Imaging Software Revenue Market Share by Players (2021–2026)
3.2 Global Top Cancer Imaging Software Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Cancer Imaging Software Revenue
3.4 Global Cancer Imaging Software Market Concentration Ratio
3.4.1 Global Cancer Imaging Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Imaging Software Revenue in 2025
3.5 Global Key Players of Cancer Imaging Software Head Offices and Areas Served
3.6 Global Key Players of Cancer Imaging Software, Products and Applications
3.7 Global Key Players of Cancer Imaging Software, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans

4 Cancer Imaging Software Breakdown Data by Type
4.1 Global Cancer Imaging Software Historic Market Size by Type (2021–2026)
4.2 Global Cancer Imaging Software Forecasted Market Size by Type (2027–2032)

5 Cancer Imaging Software Breakdown Data by Application
5.1 Global Cancer Imaging Software Historic Market Size by Application (2021–2026)
5.2 Global Cancer Imaging Software Forecasted Market Size by Application (2027–2032)

6 North America
6.1 North America Cancer Imaging Software Market Size (2021–2032)
6.2 North America Cancer Imaging Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Cancer Imaging Software Market Size by Country (2021–2026)
6.4 North America Cancer Imaging Software Market Size by Country (2027–2032)
6.5 United States
6.6 Canada

7 Europe
7.1 Europe Cancer Imaging Software Market Size (2021–2032)
7.2 Europe Cancer Imaging Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Cancer Imaging Software Market Size by Country (2021–2026)
7.4 Europe Cancer Imaging Software Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland

8 Asia-Pacific
8.1 Asia-Pacific Cancer Imaging Software Market Size (2021–2032)
8.2 Asia-Pacific Cancer Imaging Software Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Cancer Imaging Software Market Size by Region (2021–2026)
8.4 Asia-Pacific Cancer Imaging Software Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand

9 Latin America
9.1 Latin America Cancer Imaging Software Market Size (2021–2032)
9.2 Latin America Cancer Imaging Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Cancer Imaging Software Market Size by Country (2021–2026)
9.4 Latin America Cancer Imaging Software Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cancer Imaging Software Market Size (2021–2032)
10.2 Middle East & Africa Cancer Imaging Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Cancer Imaging Software Market Size by Country (2021–2026)
10.4 Middle East & Africa Cancer Imaging Software Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE

11 Key Players Profiles
11.1 Mirada
11.1.1 Mirada Company Details
11.1.2 Mirada Business Overview
11.1.3 Mirada Cancer Imaging Software Introduction
11.1.4 Mirada Revenue in Cancer Imaging Software Business (2021–2026)
11.1.5 Mirada Recent Development
11.2 GE HealthCare
11.2.1 GE HealthCare Company Details
11.2.2 GE HealthCare Business Overview
11.2.3 GE HealthCare Cancer Imaging Software Introduction
11.2.4 GE HealthCare Revenue in Cancer Imaging Software Business (2021–2026)
11.2.5 GE HealthCare Recent Development
11.3 Mint Medical
11.3.1 Mint Medical Company Details
11.3.2 Mint Medical Business Overview
11.3.3 Mint Medical Cancer Imaging Software Introduction
11.3.4 Mint Medical Revenue in Cancer Imaging Software Business (2021–2026)
11.3.5 Mint Medical Recent Development
11.4 Imaris
11.4.1 Imaris Company Details
11.4.2 Imaris Business Overview
11.4.3 Imaris Cancer Imaging Software Introduction
11.4.4 Imaris Revenue in Cancer Imaging Software Business (2021–2026)
11.4.5 Imaris Recent Development
11.5 Varian
11.5.1 Varian Company Details
11.5.2 Varian Business Overview
11.5.3 Varian Cancer Imaging Software Introduction
11.5.4 Varian Revenue in Cancer Imaging Software Business (2021–2026)
11.5.5 Varian Recent Development
11.6 DOSIsoft
11.6.1 DOSIsoft Company Details
11.6.2 DOSIsoft Business Overview
11.6.3 DOSIsoft Cancer Imaging Software Introduction
11.6.4 DOSIsoft Revenue in Cancer Imaging Software Business (2021–2026)
11.6.5 DOSIsoft Recent Development
11.7 Certis Oncology
11.7.1 Certis Oncology Company Details
11.7.2 Certis Oncology Business Overview
11.7.3 Certis Oncology Cancer Imaging Software Introduction
11.7.4 Certis Oncology Revenue in Cancer Imaging Software Business (2021–2026)
11.7.5 Certis Oncology Recent Development
11.8 MIM Software Inc.
11.8.1 MIM Software Inc. Company Details
11.8.2 MIM Software Inc. Business Overview
11.8.3 MIM Software Inc. Cancer Imaging Software Introduction
11.8.4 MIM Software Inc. Revenue in Cancer Imaging Software Business (2021–2026)
11.8.5 MIM Software Inc. Recent Development
11.9 Arterys
11.9.1 Arterys Company Details
11.9.2 Arterys Business Overview
11.9.3 Arterys Cancer Imaging Software Introduction
11.9.4 Arterys Revenue in Cancer Imaging Software Business (2021–2026)
11.9.5 Arterys Recent Development
11.10 SIEMENS
11.10.1 SIEMENS Company Details
11.10.2 SIEMENS Business Overview
11.10.3 SIEMENS Cancer Imaging Software Introduction
11.10.4 SIEMENS Revenue in Cancer Imaging Software Business (2021–2026)
11.10.5 SIEMENS Recent Development
11.11 Brainomix
11.11.1 Brainomix Company Details
11.11.2 Brainomix Business Overview
11.11.3 Brainomix Cancer Imaging Software Introduction
11.11.4 Brainomix Revenue in Cancer Imaging Software Business (2021–2026)
11.11.5 Brainomix Recent Development
11.12 Oncology Systems Limited
11.12.1 Oncology Systems Limited Company Details
11.12.2 Oncology Systems Limited Business Overview
11.12.3 Oncology Systems Limited Cancer Imaging Software Introduction
11.12.4 Oncology Systems Limited Revenue in Cancer Imaging Software Business (2021–2026)
11.12.5 Oncology Systems Limited Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer